Beyond glucose: metabolic substrate provision enhances cardiac energetics, function and stability ex vivo: a simple recipe for healthier hearts?

Clicks: 1
ID: 329336
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #122 of 123 articles by views in cardiovascular research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 123 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
AIMS: In 1932, Hans Krebs and Kurt Henseleit introduced a bicarbonate-based solution for liver perfusion containing only 5.55 mM glucose. This bicarbonate-based Krebs-Henseleit buffer (KHB) has been frequently modified over many years but typically includes only glucose as a substrate, often to hyperglycaemic levels. However, despite its popularity, hearts perfused under these conditions are close to the limits of substrate and oxygen availability and unable to sustainably respond to increased demand. The aim of the present study was to compare the function, stability and energetics of hearts perfused with standard glucose-containing KHB with those perfused with a Full Metabolic Buffer (FMB) containing a physiologically appropriate range of substrates, including (in mM): fatty acids (0.4), lactate (1), pyruvate (0.1), glucose (5), glutamate (0.5), β-hydroxybutyrate (4), and insulin (5 mIU/L). METHODS AND RESULTS: Isolated rat hearts were perfused with either KHB or FMB, followed by isoprenaline (1 μM for 20 mins) to induce stress. Cardiac function was measured via an intraventricular balloon, while energetics and metabolism were assessed with 31P and 1H NMR spectroscopy while action potential/calcium transients were assessed with cardiac optical mapping. An adapted FMB was also developed for culturing isolated cardiomyocytes, and glycolytic flux in these cells was measured with 2H NMR spectroscopy. In hearts perfused with FMB, basal left ventricular developed pressure was higher (160 ± 7 mmHg vs. 126 ± 6 mmHg in KHB), PCr/ATP ratio was elevated (1.67 ± 0.1 vs. 1.28 ± 0.05), Gibbs free energy of ATP hydrolysis was increased -2.9 ± 0.3 kJ/mol more negative, and mitochondrial membrane potential was more polarized by -19 ± 7 mV. Under stress, Langendorff-perfused FMB hearts maintained contractile function with fewer arrhythmias and maintained higher PCr/ATP ratio. The metabolic profile was significantly different between hearts perfused with either buffer, with higher levels of key mitochondrial metabolites such as succinate and fumarate in FMB hearts. FMB supressed pacing induced calcium transient duration alternans compared to KHB perfused hearts. CONCLUSION: Compared to KHB, FMB provides substantial advantages for cardiac energetics, metabolism, and function, and is therefore a more appropriate buffer to use in cardiovascular metabolism studies.
Reference Key
openalex_W7213889722 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Zoe Hoare, Yu Jin Chung, Edward C T Waters, Abbie Hayes, Katie Tompkins, Christopher O’Shea, Davor Pavlovic, Richard Southworth, Thomas R. Eykyn, Michael J. Shattock
Journal cardiovascular research
Year 2026
DOI
10.1093/cvr/cvag212
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.